Iterative Scopes AI Platform
AI-powered platform for gastrointestinal endoscopy
Company profile
Company profile
Iterative Scopes is a medical technology company focused on developing artificial intelligence solutions for gastrointestinal endoscopy. The company creates AI-powered software that assists gastroenterologists during colonoscopy procedures by providing real-time detection and characterization of polyps and other abnormalities. Their technology aims to improve the quality of colonoscopy examinations, reduce missed lesions, and enhance clinical decision-making during endoscopic procedures. By leveraging computer vision and machine learning, Iterative Scopes' solutions integrate directly into the endoscopy workflow to support physicians in delivering higher quality care. The company's products are designed to work seamlessly with existing endoscopy equipment and systems, providing augmented intelligence that complements the gastroenterologist's expertise. Iterative Scopes serves healthcare providers, ambulatory surgery centers, and hospital systems that perform gastrointestinal endoscopy procedures.
Company description Iterative Scopes official website
Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Embedded deployment with recorded integration context.
02 · Flagship portfolio
Selected source-backed Company products and the available commercial context.
AI-powered platform for gastrointestinal endoscopy
03 · Research intelligence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Medical image analysis · Dec 1, 2023
Development of a Novel Ulcerative Colitis Endoscopic Mayo Score Prediction Model Using Machine Learning.Gastro hep advances · Jan 1, 2023
Computer-Aided Detection Improves Adenomas per Colonoscopy for Screening and Surveillance Colonoscopy: A Randomized Trial.Gastroenterology · Sep 1, 2022
Improvement in adenoma detection using a novel artificial intelligence-aided polyp detection device.Endoscopy international open · Feb 1, 2021
Clinical validation
NCT04754347 · Sponsor · COMPLETED
Regulatory
K241508 · 510k · Jul 3, 2024
SKOUT® systemK240781 · 510k · Apr 19, 2024
SKOUT® systemK230658 · 510k · Apr 7, 2023
SKOUT SoftwareK213686 · 510k · Aug 12, 2022
04 · Company-reported outcomes
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
No Company-reported outcomes are currently listed.
05 · Leadership
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Recent articles published on Iterative Scopes's official website.
No Company updates are currently listed.
07 · HAIC coverage
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Curated official destinations from the active Company record.
09 · Market pathway
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Companies that apply AI to analyze medical images for diagnostic purposes, workflow optimization, or clinical decision support. Covers general radiology (X-rays, CT scans, MRIs, ultrasounds) across multiple organ systems, as well as specialized imaging in ophthalmology and dermatology.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.